NASDAQ:FORA Forian (FORA) Stock Price, News & Analysis → Biden replacement revealed? (From Paradigm Press) (Ad) Free FORA Stock Alerts $2.72 0.00 (0.00%) (As of 04/26/2024 ET) Add Compare Share Share Today's Range$2.70▼$2.8650-Day Range$2.46▼$3.6452-Week Range$1.85▼$4.15Volume15,089 shsAverage Volume26,221 shsMarket Capitalization$84.68 millionP/E Ratio8.24Dividend YieldN/APrice Target$7.67 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get Forian alerts: Email Address Forian MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside181.9% Upside$7.67 Price TargetShort InterestBearish1.23% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment-0.01Based on 5 Articles This WeekInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.04 out of 5 starsMedical Sector578th out of 914 stocksHealth Information Services Industry2nd out of 2 stocks 3.5 Analyst's Opinion Consensus RatingForian has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageForian has only been the subject of 1 research reports in the past 90 days. Previous Next 2.0 Short Interest Percentage of Shares Shorted1.23% of the float of Forian has been sold short.Short Interest Ratio / Days to CoverForian has a short interest ratio ("days to cover") of 6.6.Change versus previous monthShort interest in Forian has recently increased by 8.03%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldForian does not currently pay a dividend.Dividend GrowthForian does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for FORA. Previous Next 1.1 News and Social Media Coverage News SentimentForian has a news sentiment score of -0.01. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.32 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 5 news articles for Forian this week, compared to 4 articles on an average week.Search InterestOnly 1 people have searched for FORA on MarketBeat in the last 30 days. This is a decrease of -83% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Forian insiders have not sold or bought any company stock.Percentage Held by Insiders31.30% of the stock of Forian is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 19.25% of the stock of Forian is held by institutions. Previous Next 1.3 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Forian is 8.24, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 131.32.Price to Earnings Ratio vs. SectorThe P/E ratio of Forian is 8.24, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 170.65. Previous Next See Top Rated MarketRank™ Stocks Here Ad Prosper Trading AcademyThese AI trades triggered this morning (545% return)If you think a market crash is possible in 2024, I don't know why you're not using this yet. Click Here To Get Your Free Copy About Forian Stock (NASDAQ:FORA)Forian Inc. provides software and information solutions, proprietary data driven insights, and predictive analytics to optimize and measure the operational, clinical, and financial performance of its life science and healthcare customers. It operates through three segments: Information & Software, Services, and Other. The company's products include BioTrack, a vertically integrated point of sale, manufacturing, delivery, and cultivator software solution for dispensaries, cultivators, manufacturers, and distributors; and Cannalytics, a Software as a Service based analytics solution that provides customers with a presentation of business performance. Its products also comprise BioTrack seed-to-sale compliance traceability platform, which is used to manage the tracking and tracing of various cannabis products from cultivation to sale; and BioTrack State Traceability & Enforcement Monitoring System to ensure transparency and accountability throughout cannabis supply chain. In addition, the company offers security monitoring and web marketing services. Forian Inc. was incorporated in 2020 and is headquartered in Newtown, Pennsylvania. Forian Inc.Read More FORA Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart FORA Stock News HeadlinesApril 27, 2024 | msn.com‘Illinoise' Broadway Review: Sufjan Stevens Masterpiece Album Dances Triumphantly On StageApril 27, 2024 | msn.comReviewing Browns GM Andrew Berry’s drafts: Who hit, who missed and who still has a chance?April 27, 2024 | Prosper Trading Academy (Ad)These AI trades triggered this morning (545% return)If you think a market crash is possible in 2024, I don't know why you're not using this yet.April 26, 2024 | usatoday.comBrowns 2024 depth chart: How Cleveland's roster shapes up ahead of 2024 NFL DraftApril 23, 2024 | msn.com‘Patriots' Broadway Review: Peter Morgan Takes On Putin, Polonium & Power PlaysApril 18, 2024 | msn.com2025 Maserati GranCabrio Folgore EV Droptop Forecasts Sunny Days AheadApril 15, 2024 | markets.businessinsider.comAnalysts Are Bullish on These Healthcare Stocks: TELA Bio (TELA), Petmed Express (PETS)April 14, 2024 | globenewswire.comForian Inc. Announces the Passing of Director Martin J. WygodApril 27, 2024 | Prosper Trading Academy (Ad)These AI trades triggered this morning (545% return)If you think a market crash is possible in 2024, I don't know why you're not using this yet.April 12, 2024 | businesswire.comVerticalScope to Announce First Quarter 2024 ResultsApril 4, 2024 | msn.com21 of the best medical dramas and TV series to watch if you like Grey’s AnatomyApril 2, 2024 | msn.comA look at the 1,000 point scorers around Coshocton, Guernsey, Muskingum, Perry and Morgan countiesApril 1, 2024 | msn.comAbout the Browns & contract extensions; Nick Chubb; Cade York & more – Terry PlutoApril 1, 2024 | finance.yahoo.comForian Inc. (NASDAQ:FORA) Q4 2023 Earnings Call TranscriptMarch 31, 2024 | finance.yahoo.comForian Full Year 2023 Earnings: EPS Beats ExpectationsMarch 31, 2024 | msn.comTop 10 Most Popular Netflix Movies Right NowMarch 29, 2024 | usatoday.comMikal Bridges: 'My other dream was being a second-grade teacher'March 28, 2024 | benzinga.comRecap: Forian Q4 EarningsMarch 28, 2024 | finance.yahoo.comForian Inc (FORA) Outperforms Analyst Revenue Estimates and Achieves Positive Adjusted EBITDAMarch 28, 2024 | globenewswire.comForian Inc. Announces Fourth Quarter and Full Year 2023 Financial ResultsMarch 27, 2024 | benzinga.comEarnings Outlook For ForianMarch 23, 2024 | theguardian.com‘End of the world vibes’: why culture can’t stop thinking about apocalypseMarch 17, 2024 | msn.comWill the Browns pursue WR Mike Williams now that the Chargers have cut him? Hey, Mary Kay!March 15, 2024 | msn.comBrowns 53-man roster after the first wave of NFL free agencyMarch 14, 2024 | msn.comTKO Closes Its Stall in East Atlanta’s Southern FeedstoreMarch 14, 2024 | msn.comCheck out who made all-league in the KMAC and CBC during winter sports this seasonMarch 13, 2024 | msn.comNFL free agency 2024: Browns bring in ex-Panthers tight end Giovanni RicciSee More Headlines Receive FORA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Forian and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/28/2024Today4/27/2024Next Earnings (Estimated)5/10/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Health Information Services Sub-IndustryN/A Current SymbolNASDAQ:FORA CUSIPN/A CIK1829280 Webforian.com Phone+17203285372FaxN/AEmployees102Year FoundedN/APrice Target and Rating Average Stock Price Target$7.67 High Stock Price Target$13.00 Low Stock Price Target$5.00 Potential Upside/Downside+181.9%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio8.24 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$20.48 million Price / Sales4.13 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares31,132,000Free FloatN/AMarket Cap$84.68 million OptionableOptionable Beta1.03 7 Stocks to Buy And Hold ForeverClick the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report Key ExecutivesMr. Michael Vesey (Age 62)Chief Financial Officer Comp: $457kMr. Edward Francis Spaniel Jr. (Age 54)Executive VP, General Counsel & Secretary Comp: $395.8kMr. Max C. Wygod (Age 36)Co-Founder, CEO, President & Executive Chairman of the Board Comp: $46.88kMr. Adam H. Dublin (Age 58)Co-Founder, Chief Strategy Officer & Director Comp: $113.7kMr. Jason HoldenVice President of Corporate DevelopmentRebecca AdamsVice President of Human ResourcesPaul ReuscherChief Commercial OfficerMore ExecutivesKey CompetitorsAllurion TechnologiesNYSE:ALURAssertioNASDAQ:ASRTAclaris TherapeuticsNASDAQ:ACRSAtara BiotherapeuticsNASDAQ:ATRAARYA Sciences Acquisition Corp IVNASDAQ:ARYDView All CompetitorsInsiders & InstitutionsStaley Capital Advisers Inc.Bought 8,003 shares on 2/12/2024Ownership: 3.577%Canton Hathaway LLCBought 16,725 shares on 1/30/2024Ownership: 0.851%Martin J WygodBought 1,700 shares on 10/4/2023Total: $4,046.00 ($2.38/share)Martin J WygodBought 4,565 shares on 5/30/2023Total: $10,910.35 ($2.39/share)Martin J WygodBought 3,000 shares on 5/25/2023Total: $7,020.00 ($2.34/share)View All Insider TransactionsView All Institutional Transactions FORA Stock Analysis - Frequently Asked Questions Should I buy or sell Forian stock right now? 4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Forian in the last year. There are currently 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" FORA shares. View FORA analyst ratings or view top-rated stocks. What is Forian's stock price target for 2024? 4 Wall Street analysts have issued 12 month price targets for Forian's shares. Their FORA share price targets range from $5.00 to $13.00. On average, they anticipate the company's stock price to reach $7.67 in the next year. This suggests a possible upside of 181.9% from the stock's current price. View analysts price targets for FORA or view top-rated stocks among Wall Street analysts. How have FORA shares performed in 2024? Forian's stock was trading at $2.93 at the beginning of 2024. Since then, FORA shares have decreased by 7.2% and is now trading at $2.7201. View the best growth stocks for 2024 here. Are investors shorting Forian? Forian saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 179,000 shares, an increase of 8.0% from the March 31st total of 165,700 shares. Based on an average daily volume of 27,300 shares, the short-interest ratio is currently 6.6 days. Approximately 1.2% of the company's stock are sold short. View Forian's Short Interest. When is Forian's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Friday, May 10th 2024. View our FORA earnings forecast. How were Forian's earnings last quarter? Forian Inc. (NASDAQ:FORA) announced its quarterly earnings results on Thursday, March, 28th. The company reported ($0.01) EPS for the quarter. The company earned $5.37 million during the quarter, compared to analysts' expectations of $5.72 million. What guidance has Forian issued on next quarter's earnings? Forian updated its FY 2024 earnings guidance on Thursday, March, 28th. The company provided EPS guidance of for the period. The company issued revenue guidance of $21.5 million-$23.6 million, compared to the consensus revenue estimate of $24.0 million. How do I buy shares of Forian? Shares of FORA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:FORA) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingThey say it’s ‘unstoppable’ – How I made 43,509% Investing DailyHe Is Giving Away BitcoinCrypto Swap ProfitsProtect Your Bank Account Before It’s Too LateWeiss RatingsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Forian Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
